In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells

Clinical Immunology

Volumn 117, Issue 1, 2005, Pages 73-77

  Bessler, Hanna ^a,c   Salman, Hertzel ^a,c   Bergman, Michael ^a,c   Straussberg, Rachel ^b,c   Djaldetti, Meir ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Atorvastatin; Interleukins; Lovastatin; Mitogen response; Mononuclear cells; Pravastatin; Simvastatin

Indexed keywords

ATORVASTATIN; CYTOKINE; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MEVINOLIN; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; PRAVASTATIN; SIMVASTATIN; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MITOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; METABOLISM; MONONUCLEAR CELL;

CELL PROLIFERATION; CYTOKINES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKOCYTES, MONONUCLEAR; LOVASTATIN; MITOGENS; PRAVASTATIN; PYRROLES; SIMVASTATIN;

EID: 27244434795     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.06.014     Document Type: Article

References (27)

1. S. Bellosta, N. Ferri, L. Arnaboldi, F. Bernini, R. Paoletti, and A. Corsini Pleiotropic events of statins in atherosclerosis and diabetes Diabetes Care 23 Suppl. 2 2000 B72 B78
2. M. Sakai, S. Kobori, T. Matsumura, T. Biwa, Y. Sato, T. Takemura, H. Hakamata, S. Horiuchi, and M. Shichiri HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein Atherosclerosis 133 1997 51 59
3. Y. Shere, and Y. Shoenfeld Immunomodulation for treatment and prevention of atherosclerosis Autoimmun. Rev. 1 2002 21 27
4. J. Davignon, and L. Mabile Mechanisms of action of statins and their pleiotropic effects Ann. Endocrinol. (Paris) 62 2001 101 112
5. T. Ito, and U. Ikeda Inflammatory cytokines and cardiovascular disease Curr. Drug Targets Inflamm. Allergy 2 2003 257 265
6. E. Ascer, M.C. Bertolami, M.L. Venturinelli, V. Buccheri, J. Souza, J.C. Nicolau, J.A. Ramires, and C.V. Serano Jr. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients Atherosclerosis 177 2004 161 166
7. B. Okopien, R. Krysiak, J. Kowalski, A. Madej, D. Belowski, M. Zielinski, K. Labuzek, and Z.S. Herman The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipemia Atherosclerosis 176 2004 327 335
8. D. Sun, and G. Fernandes Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production Cell Immunol. 223 2003 52 63
9. T. Waehre, A. Yndestad, C. Smith, T. Haug, S.H. Tunheim, L. Gullestad, S.S. Froland, A.G. Semb, P. Aukrust, and J.K. Damas Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors Circulation 109 2004 1966 1972
10. H. Li, X. Li, K. Duan, and C. Li Inhibition of lovastatin on proliferation and expression of proinflammatory cytokines in cultured glomerular mesengial cells Clin. Med. J. (Engl.) 116 2003 1366 1369
11. S.P. Zhao, and D.Q. Zhang Atorvastatin reduces interleukin-6 plasma concentration and adipocyte secretion of hypercholesterolemic rabbits Clin. Chim. Acta 336 2003 103 108
12. M. Matsumoto, D. Einhaus, E.S. Gold, and A. Aderem Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors J. Immunol. 172 2004 7377 7384
13. P. Ostadal, D. Alan, P. Hajek, D. Horak, J. Vejvoda, J. Trefanec, M. Mates, and J. Vojacek The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction Mol. Cell. Biochem. 246 2003 45 50
14. I. Inoue, S. Goto, K. Mizotani, T. Awata, T. Matsunaga, S. Kiawai, T. Nakajima, S. Hokari, T. Komoda, and S. Katayama Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1 beta, interleukin-6, cycloogenase-2, and p22phox by regulation of peroxisome proliferator-activity receptor alpha (PPARalpha) in primary endothelial cells Life Sci. 67 2000 863 876
15. M. Sebestjen, I. Eber, B. Zegura, S. Simcic, M. Bozic, M.M. Fressart, and M. Stegnar Statin and fubrate treatment of combined hyperlipidemis: the effects of some novel risk factors Thromb. Haemostasis 92 2004 1129 1135
16. O. Wiklund, L. Mattsson-Hulten, E. Hurt-Camejo, and J. Oscarsson Effects of simvastatin and atorvastatin on inflammation markers in plasma J. Int. Med. 251 2002 338 347
17. N.B. Chauhan, G.J. Siegel, and D.L. Feistein Effect of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain Neurochem. Res. 29 2004 1897 18911
18. P. Ferroni, F. Martini, C.M. Cardarello, P.P. Gazzaniga, G. Davi, and S. Basili Enhanced interleukin-1 beta in hypercholesterolemia: effects of simvastatin and low-dose aspirin Circulation 108 2003 1673 1675
19. M.T. Montero, O. Hernandez, Y. Suarez, J. Matilla, A.J. Ferruelo, J. Martinez-Botas, D. Gomez-Coronado, and M.A. Lasuncion Hydromethylglutaryl- coenzyme A reductase inhibition stimulates caspase-1-activity and Th1-cytokine release in peripheral blood mononuclear cells Atherosclerosis 153 2000 303 313
20. J.F. Vamvakopoulos, and C. Green HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection BMC Cardiovasc. Disord. 3 2003 6 10
21. F. Mach Statins as immunomodulators Trasplant. Immunol. 9 2002 197 200
22. S. Youssef, O. Stuve, J.C. Patarroyo, P.J. Ruis, J.L. Radosevich, E.M. Hur, M. Bravo, D.J. Mitchell, R.A. Sobel, K. Steinman, and S.S. Zamvill The HMG-CoA reductase inhibitor, atorvastatin, promotes aTh2 bias and reverses paralysis in central nervous system autoimmune disease Nature 420 2002 78 84
23. A. McKay, B.P. Leung, I.B. Mcinnes, N.C. Thomson, and F.Y. Liew A novel antiinflammatory role of simvastatin in a murine model of allergic asthma J. Immunol. 172 2004 2903 2908
24. D.Z. Hillyard, A.J. Cameron, A.H. McIntyre, M.H. Hadden, H.E. Marshall, N. Johnston, and A.G. Jardine Inhibition of proliferation and signaling mechanisms in human lymphocytes by fluvastatin Clin. Exp. Pharmacol. Physiol. 29 2002 673 678
25. A. Vitols, B. Angelin, and G. Juliusson Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans-In vitro and in vivo studies Lipids 32 1997 255 262
26. J.A. Cuthbert, and P.E. Lipsky Promotion of human T lymphocyte activation and proliferation by fatty acids in low density and high density lipoproteins Biol. Chem. 261 1986 3620 3627
27. S. Kurakata, M. Kada, Y. Shimada, T. Komai, and K. Nomoto Effect of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro Immunopharmacology 34 1996 51 61